Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Uremic Toxicity of Advanced Glycation End Products in CKD

Abstract : Advanced glycation end products (AGEs), a heterogeneous group of compounds formed by nonenzymatic glycation reactions between reducing sugars and amino acids, lipids, or DNA, are formed not only in the presence of hyperglycemia, but also in diseases associated with high levels of oxidative stress, such as CKD. In chronic renal failure, higher circulating AGE levels result from increased formation and decreased renal clearance. Interactions between AGEs and their receptors, including advanced glycation end product specific receptor (RAGE), trigger various intracellular events, such as oxidative stress and inflammation, leading to cardiovascular complications. Although patients with CKD have a higher burden of cardiovascular disease, the relationship between AGEs and cardiovascular disease in patients with CKD is not fully characterized. In this paper, we review the various deleterious effects of AGEs in CKD that lead to cardiovascular complications and the role of these AGEs in diabetic nephropathy. We also discuss potential pharmacologic approaches to circumvent these deleterious effects by reducing exogenous and endogenous sources of AGEs, increasing the breakdown of existing AGEs, or inhibiting AGE-induced inflammation. Finally, we speculate on preventive and therapeutic strategies that focus on the AGE-RAGE axis to prevent vascular complications in patients with CKD.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03568258
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : samedi 12 février 2022 - 11:50:20
Dernière modification le : lundi 14 février 2022 - 03:46:01

Lien texte intégral

Identifiants

Citation

Andrea E. M. Stinghen, Ziad A. Massy, Helen Vlassara, Gary E. Striker, Agnes Boullier. Uremic Toxicity of Advanced Glycation End Products in CKD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (2), pp.354-370. ⟨10.1681/ASN.2014101047⟩. ⟨hal-03568258⟩

Partager

Métriques

Consultations de la notice

9